Journal articles on the topic 'Brother Of the Regulator of Imprinted Sites'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 32 journal articles for your research on the topic 'Brother Of the Regulator of Imprinted Sites.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Chen, Kefei, Wenqing Huang, Bin Huang, et al. "BORIS, Brother of the Regulator of Imprinted Sites, Is Aberrantly Expressed in Hepatocellular Carcinoma." Genetic Testing and Molecular Biomarkers 17, no. 2 (2013): 160–65. http://dx.doi.org/10.1089/gtmb.2012.0242.
Full textZhang, Yanmei, Yongfei Song, Chao Li, et al. "Brother of regulator of imprinted sites inhibits cisplatin‑induced DNA damage in non‑small cell lung cancer." Oncology Letters 20, no. 5 (2020): 1. http://dx.doi.org/10.3892/ol.2020.12114.
Full textZambrano-Galván, Graciela, Miguel Reyes-Romero, Ronell Bologna-Molina, Oscar Eduardo Almeda-Ojeda, and Obed Lemus-Rojero. "CTCFL(BORIS) mRNA Expression in a Peripheral Giant Cell Granuloma of the Oral Cavity." Case Reports in Dentistry 2014 (2014): 1–4. http://dx.doi.org/10.1155/2014/792615.
Full textLee, Hae Young, Jong In Kim, Sung Ho Cho, et al. "Expression of the Brother of the Regulator of Imprinted Sites Gene in the Sputum of Patients with Lung Cancer." Korean Journal of Thoracic and Cardiovascular Surgery 47, no. 4 (2014): 378–83. http://dx.doi.org/10.5090/kjtcs.2014.47.4.378.
Full textAkhtar, Mohammad Salman, Naseem Akhter, Arshi Talat, et al. "Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression." Oncotarget 14, no. 1 (2023): 528–41. http://dx.doi.org/10.18632/oncotarget.28442.
Full textSati, Leyla, Caroline Zeiss, Krishna Yekkala, Ramazan Demir та James McGrath. "Expression of theCTCFLGene during Mouse Embryogenesis Causes Growth Retardation, Postnatal Lethality, and Dysregulation of the Transforming Growth Factor β Pathway". Molecular and Cellular Biology 35, № 19 (2015): 3436–45. http://dx.doi.org/10.1128/mcb.00381-15.
Full textSingh, Smriti, Sathiya Pandi Narayanan, Kajal Biswas, et al. "Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect." Proceedings of the National Academy of Sciences 114, no. 43 (2017): 11440–45. http://dx.doi.org/10.1073/pnas.1708447114.
Full textEl-Sharkawy, Nahla M., Wafaa M. Radwan, Enas S. Essa, et al. "Increased expression of brother of the regulator of imprinted sites in peripheral blood neutrophils is associated with both benign and malignant breast lesions." Cytometry Part B: Clinical Cytometry 92, no. 5 (2016): 355–60. http://dx.doi.org/10.1002/cyto.b.21378.
Full textSuzuki, Teruhiko, Natsuki Kosaka-Suzuki, Svetlana Pack, et al. "Expression of a Testis-Specific Form of Gal3st1 (CST), a Gene Essential for Spermatogenesis, Is Regulated by the CTCF Paralogous Gene BORIS." Molecular and Cellular Biology 30, no. 10 (2010): 2473–84. http://dx.doi.org/10.1128/mcb.01093-09.
Full textGhochikyan, Anahit, Mikayel Mkrtichyan, Dmitri Loukinov, et al. "Elicitation of T Cell Responses to Histologically Unrelated Tumors by Immunization with the Novel Cancer-Testis Antigen, Brother of the Regulator of Imprinted Sites." Journal of Immunology 178, no. 1 (2006): 566–73. http://dx.doi.org/10.4049/jimmunol.178.1.566.
Full textKosaka-Suzuki, Natsuki, Teruhiko Suzuki, Elena M. Pugacheva, et al. "Transcription Factor BORIS (Brother of the Regulator of Imprinted Sites) Directly Induces Expression of a Cancer-Testis Antigen, TSP50, through Regulated Binding of BORIS to the Promoter." Journal of Biological Chemistry 286, no. 31 (2011): 27378–88. http://dx.doi.org/10.1074/jbc.m111.243576.
Full textNguyen, Phuongmai, Gil Bar-Sela, Lunching Sun, et al. "BAT3 and SET1A Form a Complex with CTCFL/BORIS To Modulate H3K4 Histone Dimethylation and Gene Expression." Molecular and Cellular Biology 28, no. 21 (2008): 6720–29. http://dx.doi.org/10.1128/mcb.00568-08.
Full textRenaud, S., E. M. Pugacheva, M. D. Delgado, et al. "Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors." Nucleic Acids Research 35, no. 21 (2007): 7372–88. http://dx.doi.org/10.1093/nar/gkm896.
Full textChandraSekharan, Sankaran, N. Pore, and E. Klenova. "BORIS (Brother of Regulator of Imprinting Sites) as a possible new blood marker for breast cancer." European Journal of Surgical Oncology (EJSO) 35, no. 11 (2009): 1240. http://dx.doi.org/10.1016/j.ejso.2009.07.146.
Full textHoribe, Ryota, Yoshihiko Hirohashi, Takuya Asano, et al. "Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy." PLOS ONE 12, no. 3 (2017): e0171460. http://dx.doi.org/10.1371/journal.pone.0171460.
Full textAsano, Takuya, Yoshihiko Hirohashi, Toshihiko Torigoe, et al. "Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy." Oncotarget 7, no. 10 (2016): 11223–37. http://dx.doi.org/10.18632/oncotarget.7165.
Full textOdgerel, Khongorzul, and Zsófia Bánfalvi. "In silico promoter analysis and expression of the BIG BROTHER gene in different organs of potato." Columella : Journal of Agricultural and Environmental Sciences 9, no. 1 (2022): 31–41. http://dx.doi.org/10.18380/szie.colum.2022.9.1.31.
Full textCentrella, M., S. Casinghino, J. Kim, et al. "Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype." Molecular and Cellular Biology 15, no. 6 (1995): 3273–81. http://dx.doi.org/10.1128/mcb.15.6.3273.
Full textAAPOLA, Ulla, Katja MÄENPÄÄ, Antti KAIPIA, and Pärt PETERSON. "Epigenetic modifications affect Dnmt3L expression." Biochemical Journal 380, no. 3 (2004): 705–13. http://dx.doi.org/10.1042/bj20040067.
Full textNoé, Laura, Kathleen Freson, Elke Giets, Chantal Thijs, Christine Wittevrongel, and Christel Van Geet. "Loss of Gs Activity in Platelets from Carriers with a Heterozygous Missense Mutation in the Regulator of G Protein Signaling 2 (RGS2)." Blood 112, no. 11 (2008): 2861. http://dx.doi.org/10.1182/blood.v112.11.2861.2861.
Full textZhang, Yanmei, Mengdie Fang, Yongfei Song, Juan Ren, Jianfei Fang, and Xiaoju Wang. "Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer." Scientific Reports 7, no. 1 (2017). http://dx.doi.org/10.1038/srep40786.
Full textZhou, Siqi, Lian Li, Ming Zhang, Yang Qin, and Bo Li. "The function of brother of the regulator of imprinted sites in cancer development." Cancer Gene Therapy, November 14, 2022. http://dx.doi.org/10.1038/s41417-022-00556-0.
Full textRivero-Hinojosa, Samuel, Sungyun Kang, Victor V. Lobanenkov, and Gabriel E. Zentner. "Testis-specific transcriptional regulators selectively occupy BORIS-bound CTCF target regions in mouse male germ cells." Scientific Reports 7, no. 1 (2017). http://dx.doi.org/10.1038/srep41279.
Full textDeng, Siwei, Yuliang Feng, and Siim Pauklin. "3D chromatin architecture and transcription regulation in cancer." Journal of Hematology & Oncology 15, no. 1 (2022). http://dx.doi.org/10.1186/s13045-022-01271-x.
Full textJanssen, Sanne Marlijn, Roy Moscona, Mounib Elchebly, et al. "BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells." Cell Death Discovery 6, no. 1 (2020). http://dx.doi.org/10.1038/s41420-019-0235-x.
Full textD'Arcy, Vivien, Ziedulla K. Abdullaev, Naresh Pore, et al. "The Potential of BORIS Detected in the Leukocytes of Breast Cancer Patients as an EarlyMarker ofTumorigenesis." Clinical Cancer Research, October 24, 2006. https://doi.org/10.1158/1078-0432.CCR-05-2731.
Full textPugacheva, Elena. "Comparative analyses of CTCF and BORIS occupancies uncover two distinct classes of CTCF binding genomic regions." August 1, 2015. https://doi.org/10.5281/zenodo.21405.
Full textZhang, Yanmei, Mengdie Fang, Shouye Li, et al. "BTApep-TAT peptide inhibits ADP-ribosylation of BORIS to induce DNA damage in cancer." Molecular Cancer 21, no. 1 (2022). http://dx.doi.org/10.1186/s12943-022-01621-w.
Full textYadav, Sandhya, Somnath D. Bhagat, Amit Gupta, Atul Samaiya, Aasheesh Srivastava, and Sanjeev Shukla. "Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer." BMC Cancer 19, no. 1 (2019). http://dx.doi.org/10.1186/s12885-019-6257-1.
Full textBatista, Rita A., Jordi Moreno-Romero, Yichun Qiu, et al. "The MADS-box transcription factor PHERES1 controls imprinting in the endosperm by binding to domesticated transposons." eLife 8 (December 2, 2019). http://dx.doi.org/10.7554/elife.50541.
Full textBossi, Alessandra Maria, and Devid Maniglio. "BioMIPs: molecularly imprinted silk fibroin nanoparticles to recognize the iron regulating hormone hepcidin." Microchimica Acta 189, no. 2 (2022). http://dx.doi.org/10.1007/s00604-022-05165-0.
Full textArcher, Catherine, and Kate Delmo. "Play Is a Child’s Work (on Instagram)." M/C Journal 26, no. 2 (2023). http://dx.doi.org/10.5204/mcj.2952.
Full text